Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Limosilactobacillus Reuteri as an Adjuvant in the Treatment of Peri-implant Mucositis in Total Rehabilitation: an Exploratory Study

NCT05758103 is registered in ClinicalTrials.gov with Malo Clinic as lead sponsor.

NCT NCT05758103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Limosilactobacillus Reuteri as an Adjuvant in the Treatment of Peri-implant Mucositis in Total Rehabilitation: an Exploratory Study
Lead sponsor
Malo Clinic
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2022
Completion date
September 18, 2022
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peri-implant mucositis